Indonesia on 19 June 2021
Daily infections (19 June 2021) 12,290
The current COVID-19 situation
Data reported to WHO in the last 24 hours. Latest update: 18 June 2021, 11:31 pm GMT+8.
12 990 New cases
1 963 266 Confirmed cases
54 043 Confirmed deaths
Indonesia to get Pfizer Covid-19 vaccine from August
Reuters -June 19, 2021 9:34 PM
JAKARTA: Indonesia will receive 50 million doses of the Covid-19 vaccine jointly made by Pfizer and BioNTech, with the first batch expected in August, a senior health ministry official said today.
“Pfizer vaccines will start arriving from August, with shipments of between 7.5 million to 12 million doses per month,” said Siti Nadia Tarmizi, adding that the supply is the result of a direct government purchase.
The Southeast Asia’s biggest country is grappling with a fresh increase in coronavirus infections in recent weeks. It recorded its highest daily infection figure on Friday since late January, with 12,990 cases.
The country, with a population of around 270 million people, has recorded nearly 2 million coronavirus infections since the pandemic started and 54,291 deaths, the highest in Southeast Asia.
It aims to vaccinate 181.5 million people by next year. As of today, 12.2 million people have received two doses of other vaccines.
Indonesia: Hundreds of healthcare workers contract COVID-19 despite being vaccinated with Sinovac, with dozens hospitalised…
But barely 5 weeks ago, Indonesian Health Minister praised the Sinovac vaccine to the sky but now…
Hundreds of Indonesian healthcare workers contract COVID-19 despite vaccination, dozens hospitalised
Thursday, June 17, 2021, 16:30 GMT+7
More than 350 Indonesian doctors and healthcare workers have contracted COVID-19 despite being vaccinated with Sinovac and dozens have been hospitalised, officials said, as concerns rise about the efficacy of some vaccines against more virulent virus variants.
Most were asymptomatic and self-isolating at home, said Badai Ismoyo, head of the Kudus district health office in Central Java, but dozens were in hospital with high fevers and declining oxygen saturation levels.
Kudus is battling an outbreak believed to be driven by the more transmissible Delta variant which has pushed bed occupancy rates above 90% in the district.
Designated as a priority group, Indonesian healthcare workers were among the first to be vaccinated when the inoculation drive started in January.
Almost all have received the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac, according to the Indonesian Medical Association (IDI).
While the number of Indonesian healthcare workers dying from COVID-19 has decreased significantly – dropping from 158 deaths this January to 13 this May, according to data initiative group LaporCOVID-19 – public health experts say the Java hospitalisations are cause for concern.
“The data shows they have the Delta variant [in Kudus] so it is no surprise that the breakthrough infection is higher than before because as we know the majority of healthcare workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant,” said Dicky Budiman, an epidemiologist from Australia’s Griffith University.
A spokesperson from Sinovac and Indonesia’s ministry of health were not immediately available for comment on the efficacy of Sinovac’s CoronaVac against newer coronavirus variants.
Grappling with one of the worst outbreaks in Asia, with more than 1.9 million cases and 53,000 deaths, there has been a heavy toll on Indonesia’s doctors and nurses with 946 deaths.
Many are now experiencing pandemic fatigue and taking an increasingly laissez-faire approach to health protocols after being vaccinated, said Lenny Ekawati, from LaporCOVID-19.
“That phenomenon happens quite often these days, not only within the community but also healthcare workers,” she said, “They think because they are vaccinated that they are safe.”
But as more cases of the highly transmissible Delta variant are identified in the world’s fourth most populous nation, the data is starting to tell a different story.
Across Indonesia, at least five doctors and one nurse have died from COVID-19 despite being vaccinated, according to the data initiative group, although one had only received their first shot.
A key question for all Covid-19 vaccines is whether they can prevent or deter actual transmission of the virus. Yin said on Tuesday that Sinovac does not yet know if its shot – a traditional inactivated vaccine – can stop or reduce the virus from being contracted in the first place, but the fact it is preventing serious illness and death is more important.
The mRNA shot developed by BioNTech SE and Pfizer Inc. has been shown to be over 90 per cent effective in preventing transmission in Israel.
While non-mRNA vaccines are unlikely to be that effective in preventing transmission, the growing body of evidence that Sinovac’s shot works is a boon to China’s mission of supplying the developing world in a bid to increase its influence and standing.
Sinovac’s vaccine is reported to be highly effective in wiping out Covid-19 among healthcare workers in Indonesia, an encouraging sign for the dozens of developing countries that are reliant on the Chinese vaccine. Sinovac performed far worse than western vaccines in clinical trials reported previously in other countries.
In this report, Indonesia monitored 25,374 health workers in capital city Jakarta for 28 days after they received their second dose and found that the Sinovac vaccine protected 100% of them from death and 96% from hospitalization as soon as seven days after, said Health Minister Budi Gunadi Sadikin.
He also said that 94% of the workers had been protected against infection — an extraordinary result that goes beyond what was measured in numerous clinical trials — though it’s unclear if the workers were uniformly screened to detect asymptomatic carriers.